CTOs on the Move

Spero Health

www.sperohealth.com

 
When it comes to treating addiction to opioids and other substances, there`s no single magic bullet. Rather, it takes a combination of tools to surround patients with care and keep them on the road to recovery. Spero Health delivers outpatient care to treat patients close to home in their own environments so they can cope with life as they overcome addiction. We create an individualized treatment plan for each patient using a pioneering, proven, three-pronged approach: 1. Evidence-based physician services • Physician visit • Mental and physical health screenings • Individualized recovery plan • Medication-assisted treatment, which may include Suboxone® ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Edward Littlejohn
Chief Operating Officer Profile

Similar Companies

Benvenue Medical

Founded in 2004, Benvenue Medical, Inc. provides next generation minimally invasive systems for spine repair that combine expandable implants with novel delivery instruments to provide enduring functional benefits for patients. The company is privately held and funded by InterWest Partners, Versant Ventures, DeNovo Ventures, Domain Associates and Technology Partners. Its first products are designed for the treatment of vertebral compression fractures and degenerative disc disease, which have combined revenues of $9 billion globally.

Carol Cole Company

Carol Cole Company is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lancer Orthodontics

Lancer Orthodontics, Inc is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Medical Vision Technologies

American Medical Vision Technologies LLC is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

INTEGRATED MEDICAL TECHNOLOGIES USA

INTEGRATED MEDICAL TECHNOLOGIES USA is a Circle Pines, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.